Bindarit

DB12739InvestigationalSmall molecule

Bindarit has been used in trials studying the prevention and treatment of Coronary Restenosis and Diabetic Nephropathy.

Chemical structure of Bindarit
Formula / weight
C19H20N2O3 · 324.38 g/mol (avg)
Code names
AF-2838

Resolves to

Compound
UNIIJQ11LH711MCAS130641-38-2ChEMBLCHEMBL2107549PubChem71354
Structure
InChIKeyMTHORRSSURHQPZ-UHFFFAOYSA-NSMILESCC(C)(OCC1=NN(CC2=CC=CC=C2)C2=CC=CC=C12)C(O)=O
Targets
P13500CCL2

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Bindarit, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In